Thrombotic Microangiopathies: Multimers, Metalloprotease, and Beyond

被引:18
作者
Moake, Joel [1 ]
机构
[1] Rice Univ, Houston, TX 77251 USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2009年 / 2卷 / 05期
关键词
TTP; HUS; other thrombotic microangiopathies; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC SYNDROME; FACTOR-H-AUTOANTIBODIES; VONWILLEBRAND-FACTOR MULTIMERS; PLATELET GLYCOPROTEIN-IB; THROMBOCYTOPENIC PURPURA; ENDOTHELIAL-CELLS; AURINTRICARBOXYLIC ACID; DEFICIENT ACTIVITY;
D O I
10.1111/j.1752-8062.2009.00142.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The pathophysiology of various types of thrombotic microangiopathies is coming progressively into focus. Therapeutic advances are likely to follow at a quickening pace. This discussion focuses on thrombotic thrombocytopenic purpura (TTP), the hemolytic-uremic syndrome (HUS), thrombotic microangiopathies associated with transplantation-immunosuppression or anti-angiogenesis therapy, and the preeclampsia/hemolysis-elevated liver enzymes and low platelets syndrome (HELLP).
引用
收藏
页码:366 / 373
页数:8
相关论文
共 61 条
[21]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[22]   Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Wassmer, M ;
Sandoz, P ;
Lammle, B .
BLOOD, 1997, 89 (09) :3097-3103
[23]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[24]   First-in-human evaluation of anti-von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers [J].
Gilbert, James C. ;
DeFeo-Fraulini, Tia ;
Hutabarat, Renta M. ;
Horvath, Christopher J. ;
Merlino, Patricia G. ;
Marsh, H. Nicholas ;
Healy, Judith M. ;
BouFakhreddine, Sleiman ;
Holohan, Thomas V. ;
Schaub, Robert G. .
CIRCULATION, 2007, 116 (23) :2678-2686
[25]  
JILMA B, 2008, AM SOC HEM ANN M
[26]   Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency [J].
Jozsi, Mihaly ;
Licht, Christoph ;
Strobel, Stefanie ;
Zipfel, Svante L. H. ;
Richter, Heiko ;
Heinen, Stefan ;
Zipfel, Peter F. ;
Skerka, Christine .
BLOOD, 2008, 111 (03) :1512-1514
[27]   Anti-factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome [J].
Jozsi, Mihaly ;
Strobel, Stefanie ;
Dahse, Hans-Martin ;
Liu, Wei-Shih ;
Hoyer, Peter F. ;
Oppermann, Martin ;
Skerka, Christine ;
Zipfel, Peter F. .
BLOOD, 2007, 110 (05) :1516-1518
[28]   THE ASSOCIATION BETWEEN IDIOPATHIC HEMOLYTIC UREMIC SYNDROME AND INFECTION BY VEROTOXIN-PRODUCING ESCHERICHIA-COLI [J].
KARMALI, MA ;
PETRIC, M ;
LIM, C ;
FLEMING, PC ;
ARBUS, GS ;
LIOR, H .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (05) :775-782
[29]   Cognitive deficits after recovery from thrombotic thrombocytopenic purpura [J].
Kennedy, April S. ;
Lewis, Qurana F. ;
Scott, James G. ;
Hovinga, Johanna A. Kremer ;
Laemmle, Bernhard ;
Terrell, Deirdra R. ;
Vesely, Sara K. ;
George, James N. .
TRANSFUSION, 2009, 49 (06) :1092-1101
[30]   Epitope mapping of ADAMTS 13 autoantibodies in acquired thrombotic thrombocytopenic purpura [J].
Klaus, C ;
Plaimauer, B ;
Studt, JD ;
Domer, F ;
Lämmle, B ;
Mannucci, PM ;
Scheiflinger, F .
BLOOD, 2004, 103 (12) :4514-4519